Your search returned 2 results.

Results
	1.	Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results. [electronic resource] by Selmaj, Krzysztof Barkhof, Frederik Belova, Anna N Wolf, Christian van den Tweel, Evelyn Rw Oberyé, Janine Jl Mulder, Roel Egging, David F Koper, Norbert P Cohen, Jeffrey A Producer: 20180713 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study. [electronic resource] by Banerji, Udai van Herpen, Carla M L Saura, Cristina Thistlethwaite, Fiona Lord, Simon Moreno, Victor Macpherson, Iain R Boni, Valentina Rolfo, Christian de Vries, Elisabeth G E Rottey, Sylvie Geenen, Jill Eskens, Ferry Gil-Martin, Marta Mommers, Ellen C Koper, Norbert P Aftimos, Philippe Producer: 20200619 In: The Lancet. Oncology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search